C3.ai Has the Best Ticker in AI (NYSE: AI) — and a Shrinking Business

DeepRead Research
Sep 07

① THE FILTER — what we screened out, what we kept

We scanned 18+ analyst actions on AI after its Sep 2 Q1 FY2027 print and the company profile. This is the batch's cautionary tale: the enterprise-AI name that isn't growing.

We cut: the "named a Leader in AI Platforms" PR and the great-ticker novelty.
We kept the hard stuff:

  • **Q1 FY2027 (reported Sep 2): revenue $$52.4M** — it *"beat guidance,"* but that guidance was **lowered**: revenue **fell ~25% YoY** (from$$70.3M a year ago). GAAP gross margin ~33%; net loss −$$92.8M**; free cash flow turned **positive ($$2.06M) for the first time in this set on aggressive cost cuts.

  • FY27 guidance ($$210–240M) is BELOW the$$224M consensus midpoint, and Q2 guide ($51–55M) is light.

  • A CEO transition (Stephen Ehikian succeeded founder Tom Siebel as CEO in late 2025; Siebel is executive chairman).

  • Consensus Sell / Reduce (12 analysts). Avg target **~$$8.7–8.8 — BELOW the current price (−16% "downside")**, high$$15, low $6.


📊 BULL vs BEAR — the analyst split

Camp

Count

Share

Bar

🟢 Bullish (Buy)

1

8%

▊░░░░░░░░░

🟡 Neutral (Hold)

4

33%

███▎░░░░░░

🔴 Bearish (Sell)

7

58%

█████▊░░░░

The only Sell-majority book in this batch (58% Sell). The lone bull (Wedbush's Dan Ives, $15) stands against a wall of Underperform/Underweight ratings and a consensus target below the stock price. This is a name the Street is actively telling you to avoid.


② CORE LOGIC — the one-page thesis & the expectation gap

The thesis in one line: C3.ai is the enterprise-AI-hype casualty — a company with "AI" in its ticker whose revenue is actually shrinking, now betting a cost-cut turnaround and federal/defense bookings can revive it.

What the market is really betting on (the expectation gap):

In the biggest AI boom in history, C3.ai's revenue is declining ~25% YoY — a stunning disconnect. The expectation gap is credibility: the bull hope is that cost cuts (FCF just turned positive), a new CEO, and strong federal/defense bookings stabilize the business; the Sell-majority Street sees a sub-scale, unprofitable, decelerating company being lapped by Palantir, Microsoft, and the hyperscalers. The consensus target below the price says the market expects more downside, not a turnaround.

  • Bull case (thin): FCF turned positive on $135M of annualized cost cuts; federal/defense bookings reportedly strong; a new CEO with government ties; a real (if small) enterprise-AI platform. A deep-value/turnaround lottery ticket.

  • Bear case (consensus): Revenue is falling ~25%, deeply GAAP-unprofitable, Sell-rated, target below price, and out-executed by Palantir and the hyperscalers. Reliance on a few big partners; the "AI platform" hasn't translated to growth.

Edge vs. the crowd: C3.ai is the "AI ticker ≠ AI winner" lesson — a stark contrast to the software names that rose on real AI monetization (Salesforce, GitLab, DocuSign). When even the AI boom can't grow your revenue, the story is execution, not opportunity. This is a speculative turnaround, not an AI growth play — and the Street is betting against it.


③ ACTION SIGNALS — dual watch

A. Catalyst / research window (dates to circle)

  • 🔴 Q2 FY2027 earnings — ~December 2026. Watch whether revenue stops declining — the single most important number.

  • 🟡 Federal / defense bookings conversion to revenue — the bull's one hope.

  • 🟡 New-CEO strategy + Baker Hughes / partner renewals — the execution reset.

  • 🟢 Cash burn / FCF durability — can positive FCF hold?

B. Earnings-preview watch (what "good" vs "bad" looks like)

Watch

Good

Warning

Revenue

Returns to growth

Keeps declining

Bookings → revenue

Federal converts

Backlog without revenue

FCF

Stays positive

Reverts to burn

Guidance

Above consensus

Cut again

⚠️ Avoid-until-proven note: With a Sell consensus, a target below the price, and revenue shrinking in an AI boom, C3.ai is the highest-skepticism name here. The turnaround needs revenue to simply stop falling first. Treat any position as a speculative bet against the Street's clear "sell" signal — size accordingly.


④ VALUE CHAIN & FOCUS NAMES

Upstream / inputs

  • Cloud infrastructure (hyperscaler partners); LLMs for its generative-AI layer

C3.ai's engines

  • 🧠 C3 Agentic AI Platform — the core enterprise-AI software

  • 🏭 Industry AI apps — energy, defense, manufacturing (Shell, Baker Hughes)

  • 🏛️ Federal / defense — the bookings bright spot; the turnaround hope

Downstream / competition

  • Palantir (the enterprise-AI winner), Microsoft, hyperscalers (AWS/Google/Azure AI), Snowflake/Databricks

Focus names to track alongside AI

  • Palantir (PLTR): the enterprise-AI name that is growing — the direct contrast.

  • Salesforce / GitLab / DocuSign: the "real AI monetization" software winners.

  • Baker Hughes / Shell: the key partners C3.ai depends on.


Sources (free/public): stockanalysis.com/AI · MarketBeat AI price targets · C3.ai results coverage · Wikipedia. Figures as reported by sources; GAAP basis. Revenue-decline and Sell-consensus flagged as the key facts. As of Sep 7, 2026.
🤖 Auto-compiled by AI from free public information. For research/education only — not investment advice.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10